US Fertility AI Market Strategy Report - Fertility Clinics

Answer Capsule

US Fertility holds the weakest recommendation position in the September 2026 Fertility Clinics benchmark, with zero valid recommendations across 332 qualified observations. The brand appears in only 1.2% of qualified observations, and none of those mentions convert into a recommendation, top-three placement, or rank-one result. The clearest weakness is a total absence of recommendation conversion in AI-generated fertility clinic recommendations. The clearest opportunity is building a public evidence layer that gives AI systems a reason to recommend the brand in high-intent fertility clinic prompts.

Who This Report Is For

This report is for marketing, growth, and executive teams at US Fertility responsible for understanding how AI-generated recommendations are shaping patient decisions in fertility clinic selection and where the brand currently stands in AI-assisted discovery.

Report Card

Executive Summary

US Fertility holds the weakest position in the September 2026 Fertility Clinics benchmark. The brand generated zero valid recommendations across 332 qualified observations, meaning AI systems never once recommended US Fertility when responding to high-intent fertility clinic prompts. This is not a case of weak placement or low rank; it is a total absence of recommendation-stage visibility.

The brand appeared in only 4 of 332 qualified observations, a raw mention presence rate of 1.2%. All four mentions were neutral, with no positive framing and no negative framing. US Fertility is the only tracked brand in the benchmark with zero valid recommendations, zero top-three placements, and zero rank-one results in September 2026.

The strongest cluster for the category is Best IVF Clinics & Top Fertility Centers, which captured all 332 qualified observations. US Fertility has no presence in comparison or pricing clusters, as the public benchmark recorded no qualified observations in those intent classes for any brand. The clearest platform gap spans the entire tracked surface set, with US Fertility absent from ChatGPT, Copilot, Gemini, Perplexity, and AI Overviews, and present only as a neutral mention in Google AI Mode.

The core issue is not visibility quality but visibility existence. US Fertility is effectively invisible to AI systems at the moment of recommendation, and the public evidence layer contains too little for AI systems to retrieve, cite, or synthesize in favor of the brand.

What US Fertility Is Winning

US Fertility has no evidence-backed wins in the September 2026 benchmark. The brand recorded no valid recommendations, no top-three placements, no rank-one results, and no positive mentions across 332 qualified observations.

The only positive signal is the absence of negative framing. US Fertility received zero negative mentions, meaning AI systems did not caution against the brand in any tracked observation. This is a neutral baseline rather than a competitive advantage, and it does not offset the total lack of recommendation conversion.

Where US Fertility Has the Clearest AI Visibility Gaps

Questions This Section Answers

• Why does US Fertility have zero valid recommendations despite appearing in 1.2% of qualified observations?
• How does US Fertility's recommendation coverage compare to the category leader CCRM Fertility?
• What does the August-to-September movement reveal about US Fertility's recommendation trend?

US Fertility's clearest gap is the complete absence of recommendation conversion. The brand is mentioned in 1.2% of qualified observations, but none of those mentions become recommendations. Every other tracked brand with measurable presence converts at least some mentions into valid recommendations, including Illume Fertility at 0.6% coverage and Boston IVF at 2.4% coverage.

The gap to the category leader is substantial. CCRM Fertility holds 29.5% valid recommendation coverage, a 29.5-point advantage over US Fertility. CCRM Fertility also converts 10.5% of all observations into rank-one recommendations, a rate US Fertility cannot approach because it never receives a recommendation at any rank.

US Fertility's presence is confined to Google AI Mode, where it appeared in 4 of 90 observations, all neutral. The brand has no presence on ChatGPT, Copilot, Gemini, Perplexity, or AI Overviews. This platform concentration suggests the public evidence layer is too thin for most AI systems to retrieve or cite US Fertility in fertility clinic recommendations.

The August-to-September movement shows no improvement. US Fertility held 0.4% valid recommendation coverage in July 2026 and fell to 0.0% in both August and September 2026. The brand has now recorded two consecutive months without a single valid recommendation.

Biggest Opportunity

Questions This Section Answers

• What is the root cause of US Fertility's invisibility in AI-generated fertility clinic recommendations?
• Why won't on-site content alone fix US Fertility's recommendation-stage visibility problem?

The clearest opportunity for US Fertility is building a public evidence layer that gives AI systems retrievable, citable, and recommendation-ready content. The brand's problem is not framing quality or rank position; it is that AI systems have almost nothing to retrieve. US Fertility needs authoritative, third-party-visible content across clinic locations, treatment specialties, success metrics, medical team credentials, and patient experience narratives that AI systems can cite when answering best-clinic and top-fertility-center prompts.

This is a foundational visibility problem. Until US Fertility appears in the sources AI systems draw from, no amount of on-site content or traditional search optimization alone will produce recommendation-stage visibility.

Competitive Landscape

Questions This Section Answers

• Which fertility clinic brands hold the strongest recommendation positions in the September 2026 benchmark?
• Where does US Fertility sit relative to the rest of the tracked competitive set?

CCRM Fertility, Shady Grove Fertility, and RMA Network hold the strongest recommendation positions in the Fertility Clinics category, with US Fertility at the bottom of the tracked set.

Average recommended rank covers rank-eligible recommendations only.

US Fertility sits at the bottom of the competitive set with no top-three placements, no rank-one results, and no rank-eligible recommendations. The brands above it all hold at least some recommendation coverage, with the top three converting presence into recommendation at rates between 19.9% and 29.5%.

Prompt Evidence

Google AI Mode / Best IVF Clinics & Top Fertility Centers Prompt: "best fertility clinics" Result: US Fertility appeared as a neutral mention in a small share of responses, with no recommendation and no positive framing.

ChatGPT / Best IVF Clinics & Top Fertility Centers Prompt: "top fertility centers" Result: US Fertility did not appear in any ChatGPT response, receiving zero mentions across 40 observations.

Perplexity / Best IVF Clinics & Top Fertility Centers Prompt: "recommended IVF clinics" Result: US Fertility received zero mentions across 15 observations, with no retrievable presence in Perplexity responses.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit Map the specific prompts where US Fertility is absent and identify which competitors capture the recommendations instead.

Phase 2: Recommendation Readiness Plan Define the clinical, geographic, and outcome narratives that AI systems currently lack for US Fertility.

Phase 3: Owned Answer Layer Buildout Develop authoritative owned content that directly answers high-intent fertility clinic questions with US Fertility as the recommended option.

Phase 4: Citation / Authority Layer Development Build third-party citations and source footprint so AI systems can retrieve and attribute US Fertility across the tracked surfaces.

Phase 5: Monthly AI Visibility and Recommendation Tracking Measure whether presence converts into valid recommendations and whether top-three and rank-one rates improve over time.

Why This Matters

Questions This Section Answers

• How is AI-assisted discovery routing potential patients away from US Fertility?
• What is the practical consequence of US Fertility's complete absence from AI-generated shortlists?

AI systems are becoming the first stop for patients researching fertility clinics. When a prospective patient asks which clinic to consider, the brands named in the response form the initial shortlist. US Fertility is not on that shortlist in any tracked observation, which means AI-assisted discovery is routing potential patients to competitors before US Fertility has a chance to compete.

Presence alone is not enough, but absence is disqualifying. US Fertility needs to move from invisible to present, then from present to recommended. The next move is building the prompt, page, and citation layers that give AI systems a reason to name the brand.

Core Metrics

Sentiment Score

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

For US Fertility, the calculation is (0 × 1 + 4 × 0 + 0 × -1) / 4 = 0.00.

This score matters because unclassified mention counts are misleading. US Fertility has four mentions, but all four are neutral references with no recommendation value. Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, neutral reference, cautionary mention, and competitor-displaced mention are not equal. Counting all mentions as wins is bad measurement. Classified sentiment is required before interpreting AI visibility, and for US Fertility the classification shows presence without any positive recommendation signal.

Sentiment by Platform

Methodology

1. This report is a benchmark-based analysis of US Fertility's AI recommendation visibility in the Fertility Clinics vertical, using the LLM Authority Index AI Market Discovery Index as the evidence source.
2. The reporting window is September 2026, with July and August 2026 referenced for movement context.
3. Six canonical AI/search surface families were tracked: ChatGPT, Copilot, Gemini, Perplexity, AI Overviews, and AI Mode.
4. The benchmark began with 567 source prompt-surface observations in September 2026, producing 407 unique questions.
5. All 567 prompts mentioned a tracked brand or competitor; 498 were relevant to the category and 69 were irrelevant.
6. After qualification, 332 observations formed the public denominator for all brand-level metrics.
7. The competitor universe includes 10 tracked fertility clinic brands: CCRM Fertility, Shady Grove Fertility, RMA Network, NYU Langone Fertility, Kindbody, Pacific Fertility Center, Spring Fertility, Boston IVF, Illume Fertility, and US Fertility.
8. All qualified observations fell into the Brand Recommendation cluster, which captures queries where AI systems recommend a specific clinic or clinics.
9. A mention is defined as any qualified observation where the brand appears, regardless of context.
10. A valid recommendation is defined as a qualified observation where the brand receives a positive recommendation with a rank position.
11. The public benchmark does not measure market share, attributable sales, organic-search ranking performance, social media volume, or private channel performance.
12. Small-count movements, including US Fertility's zero-recommendation result, reflect individual observations and may not indicate a durable pattern. The benchmark records changes in AI recommendation behavior; it does not establish why those changes occurred.

Get Your AI Visibility Audit

The public benchmark shows where US Fertility stands in AI-generated fertility clinic recommendations, but it does not reveal which prompts competitors win, which sources AI systems cite, or what content would move the brand from invisible to recommended. A company-level AI visibility audit maps those prompt, surface, competitor, and evidence-source patterns into a prioritized visibility strategy for moving from mention to recommendation.